ARCHIVES

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

January 27, 2006

Letter: The Lesson From Dana-Farber

July 28, 1995

Yarbro Leaves Centers Program With Pitch for More Money for Core Grants, Community Outreach, Control

July 18, 1975

$20 Million In Construction Funds Approved

April 2, 1976

Kennedy Bills Would Raise Salaries, Restore Construction, Expand Biomedical Research Support

July 14, 1989

Review Panel: NCI Intramural Program Is Too Large, Redundant, Hierarchical

May 19, 1995